1. (1) A batch of cannabinoid product shall have the following determined and listed on the COA:

   1. (a) quantity of any cannabinoid it is known to contain, including any THC analog; and
   2. (b) the cannabinoid profile by percentage of mass.
2. (2) Cannabinoid products may not exceed the cannabinoid product THC level.

3. (3) A lot or batch of cannabis plant product, cannabis concentrate, or cannabis product fails quality assurance testing for cannabinoid content if:

   1. (a) any of the artificially derived cannabinoids listed in Table 1 are found to be present; or
   2. (b) greater than 10% of the total cannabinoid peak area is comprised of unknown cannabinoids after peaks smaller than 1% of the total peak area have been excluded as determined by high-performance liquid chromatography with a diode array detector (HPLC-DAD); or
   3. (c) a newly identified cannabinoid approved by the department is present in a quantity greater than 2% by mass.

4. (4)(a) The department recognizes the following as newly identified cannabinoids:

   1. (b) Cannabicitran (CBTC), CAS 31508-71-1.

      TABLE 1Artificially Derived CannabinoidsAnalyteChemical Abstract Service (CAS) Registry numberHexahydrocannabinol (HHC)36403-90-4, 36403-91-53-Heptyl-delta(1)-tetrahydrocannabinol (THCP)54763-99-4, 51768-60-6tetrahydrocannabinol acetate (THC-OAc)23132-17-4, 23050-54-6

KEY: industrial hemp, cannabinoid, testing

Date of Last Change: August 18, 2025

Authorizing, and Implemented or Interpreted Law: 4-41-204(2)